Weight Loss Drug Novo Nordisk
Weight Loss Drug Novo Nordisk. The Food and Drug Administration has approved a Novo Nordisk diabetes drug as a treatment for obesity. Approved was Novo's Saxenda for use in managing weight in conjunction with diet and exercise.
In a statement, Novo Nordisk said that it plans to start a Phase III clinical development programme later this year to explore the potential of once-weekly semaglutide as a treatment for people with obesity. Novo Nordisk uses its own cookies as well as cookies from third parties. Novo Nordisk diabetes drug demonstrates weight loss in obese adults.
Novo Nordisk diabetes drug demonstrates weight loss in obese adults.
It's the first injectable drug approved for weight loss.
FDA clears Novo Nordisk's weight loss drug Saxenda. Novo Nordisk is not responsible for the content of the site you are about to visit. The drug, a higher dose of the blockbuster diabetes treatment liraglutide, is an analog of.
Post a Comment for "Weight Loss Drug Novo Nordisk"